Covidien Acquires CNS Therapeutics for $100,000,000

  • Feed Type
  • Date
    9/25/2012
  • Company Name
    CNS Therapeutics
  • Mailing Address
    332 Minnesota Street Saint Paul, MN 55101
  • Company Description
    CNS Therapeutics develops and brings to market safe, high-quality pharmaceuticals for site-specific delivery to the central nervous system. Gablofen (baclofen injection) marks first breakthrough for CNS Therapeutics.
  • Website
    http://www.gablofen.com
  • Transaction Type
    M&A
  • Transaction Amount
    $100,000,000
  • Transaction Round
  • Proceeds Purposes
  • M&A Terms
    Additional financial terms of the transaction were not disclosed by the parties.

By posting a comment, you agree to our terms and conditions.